Health‐Related Quality of Life and Survival among HIV‐Infected Patients Receiving Highly Active Antiretroviral Therapy: A Study of Patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort
Author(s) -
Indrek Kolk,
Mirjam A. G. Sprangers,
Jan M. Prins,
Colette Smit,
Frank de Wolf,
Pythia T. Nieuwkerk
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/649216
Subject(s) - medicine , quartile , proportional hazards model , survival analysis , quality of life (healthcare) , cohort , sida , antiretroviral therapy , cohort study , log rank test , human immunodeficiency virus (hiv) , viral load , viral disease , immunology , confidence interval , nursing
Previous studies have shown that health-related quality of life (HRQL) predicts survival in patients infected with human immunodeficiency virus (HIV). However, these studies predated the highly active antiretroviral therapy (HAART) era, included only a few patients receiving HAART, or had a limited duration of follow-up. This study investigates whether HRQL predicts survival among HIV-infected patients receiving HAART.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom